# Low Dose Versus High Dose Methylene Blue in Septic Patients

> **NCT06005558** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 90 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Methylene Blue low dose
- **DRUG:** Methylene Blue high dose

## Key facts

- **NCT ID:** NCT06005558
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-05-15
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005558, "Low Dose Versus High Dose Methylene Blue in Septic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06005558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*